Status:
RECRUITING
The Effect of Acute Exogenous Oral Ketone Supplementation on Immune Cells Function and Immune Cells Histone Β-hydroxybutyrylation
Lead Sponsor:
University of British Columbia
Conditions:
Ketosis, Metabolic
Immune Functions
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
To conduct a single-arm pilot study to determine how acute ingestion of an exogenous ketone monoester supplement alters the histone lysine β-hydroxybutyrylation and immune function in healthy human mo...
Eligibility Criteria
Inclusion
- Over the age of 19
- Able to fast overnight
Exclusion
- Being a competitive endurance athlete.
- Following a ketogenic diet, low-calorie diet, periodic fasting regimen, or regularly consuming ketogenic supplements.
- Being unable to travel to and from the university
- Being pregnant.
- Having been diagnosed with a chronic disorder of glucose or fat metabolism, including type 2 diabetes, chronic pancreatitis, or gallbladder disease
- Being unable to read or communicate in English.
Key Trial Info
Start Date :
October 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT06590623
Start Date
October 1 2024
End Date
June 1 2025
Last Update
March 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of British Columbia Okanagan Campus
Kelowna, British Columbia, Canada, V1V1V7